As part of Janus Capital's (JNS) offerings of so-called "thematic ETFs," investors have the opportunity to invest in portfolios tied to companies leading the charge of health-and-fitness innovation, the investment fund said in a Monday tweet.
"Thematic ETFs provide investors with the opportunity to invest in companies that could benefit from the transformational forces changing our future," Janus said in a linked-to report. "These powerful forces -- whether economic, cultural, behavioral or political -- are potential catalysts for sustainable, long-term growth."
Meanwhile, the research arm of Credit Suisse (CS) estimated Monday that hikes in U.S. drug prices throughout 2015 have primarily benefited a handful of pharmaceutical stocks. The top beneficiaries include AbbVie (ABBV), Amgen (AMGN) and Eli Lilly (LLY), according to Credit Suisse.
StockTwits also tweeted about how the levels of volatility on Wall Street have been spiking lately, with the VIX index jumping roughly 13% Monday.
¿ StockTwits (@StockTwits) June 13, 2016
-- Written by James Passeri